Mycoplasma Hominis BY PCR

Mycoplasma Hominis BY PCR is a molecular diagnostic test that detects the genetic material of Mycoplasma hominis in genital or urine specimens using highly sensitive polymerase chain reaction (PCR) technology. The assay provides qualitative detection of the organism and typically reports a cycle threshold (Ct) value and internal control to confirm sample adequacy. Because M. hominis can be difficult to culture and may be associated with urethritis, cervicitis, pelvic inflammatory disease and adverse pregnancy outcomes, PCR testing improves diagnostic accuracy and helps guide appropriate treatment.

This test is recommended for individuals with urogenital symptoms, patients undergoing infertility evaluation or assisted reproductive procedures, and pregnant patients or those with recurrent genital infections where targeted therapy is required. Home sample collection across Dubai is available for convenience and confidentiality, with results delivered promptly to support clinical decision-making and timely antimicrobial selection in coordination with your healthcare provider.

• Mycoplasma hominis DNA (qualitative PCR)
• Cycle Threshold (Ct) value
• Internal control (sample adequacy)
• Reported specimen type (vaginal/cervical swab, urethral swab, first-catch urine)

• Unusual or persistent genital or urinary discharge
• Painful or burning urination and lower pelvic pain
• Recurrent genital infections despite prior treatment
• Infertility workup or prior to assisted reproductive technology (ART)
• Pregnancy with risk factors for adverse outcomes or preconception screening

• High sensitivity and specificity for Mycoplasma hominis detection
• Rapid, actionable results to guide targeted antibiotic therapy
• Convenient and confidential home sample collection across Dubai
• Detailed report including Ct value and sample adequacy indicators
• Results suitable for review by UAE healthcare providers and specialists

• Home collection of genital swab (vaginal/cervical or urethral) or first-catch urine by trained technician
• Avoid sexual intercourse, douching, vaginal creams, or intravaginal medications for 24–48 hours before sampling
• If currently taking antibiotics, inform the collector or clinician as treatment can affect results
• Provide relevant clinical history and any recent test or treatment information to assist interpretation